Ms Isabel Antholz is the Managing Director of Mannin GmbH, a biotech company based in Leipzig developing therapeutics based on small molecules. Prior to her role at Mannin, she led the branch “R&D and Government Incentives” at Deloitte for some years advising clients of all industries in the area of public funding. Using her background as a lawyer and her curiosity for innovative products and business models, she also has founded her own company “Innovation Angel UG” to support established as well as recent innovators to succeed with their ideas.
Isabel Antholz will be taking part in a panel discussion on Disruptive Innovation: New Solutions to Key Pharma Supply Chain Issues at FlyPharma Europe 2022.
